Which laboratory tests should be ordered for a 7-year-old child with obesity?

Laboratory Testing for a 7-Year-Old with Obesity

For a 7-year-old child with obesity (BMI ≥95th percentile), you should order a fasting lipid panel and ALT; additional testing for glucose abnormalities should be deferred until age 10 or older unless there are specific high-risk features present. 1

Core Screening Tests

The 2017 Endocrine Society Clinical Practice Guideline provides the framework for laboratory evaluation in pediatric obesity 1:

Recommended Tests for All Children with BMI ≥85th Percentile:

• Fasting lipid profile - Screen for dyslipidemia 1

  • Total cholesterol, LDL, HDL, triglycerides
  • Abnormal values: Total cholesterol ≥170 mg/dL, LDL ≥110 mg/dL, HDL <40 mg/dL, triglycerides ≥75 mg/dL (ages 0-9)

• ALT (alanine aminotransferase) - Screen for NAFLD 1

  • New pediatric thresholds: >25 U/L for boys, >22 U/L for girls
  • Even mildly elevated ALT can indicate significant liver pathology including advanced fibrosis
  • ALT is the most practical screening tool despite underestimating liver injury

Age-Specific Considerations for Diabetes Screening

Critical caveat: Your patient is 7 years old, which is below the typical screening age for diabetes.

Standard diabetes screening recommendations apply to children ≥10 years of age or after puberty onset 1. However, consider earlier testing if:

• Strong family history of type 2 diabetes in first- or second-degree relatives
• Signs of insulin resistance (acanthosis nigricans)
• Maternal history of diabetes or gestational diabetes during the child's gestation
• High-risk ethnicity (Native American, African American, Latino, Asian American, Pacific Islander)

If Diabetes Screening Is Indicated:

Do NOT use HbA1c alone - it has poor diagnostic performance in pediatrics, underestimating prevalence of both prediabetes and diabetes 1. The preferred approach:

1. Fasting plasma glucose (preferred initial test)

   • Prediabetes: 100-125 mg/dL
   • Diabetes: ≥126 mg/dL

2. 2-hour oral glucose tolerance test - Most cost-effective strategy at $390 per case identified, with 100% effectiveness compared to HbA1c (7-32% effectiveness, $938-$3370 per case) 1

Tests to AVOID

Do NOT measure insulin levels 1 - The guideline explicitly recommends against this (strong recommendation, 1|⊕⊕⊕◯):

• No diagnostic value for insulin resistance in clinical practice
• Considerable overlap between insulin-resistant and insulin-sensitive youth
• No well-defined cutoff differentiating normal from abnormal
• Lack of standardized assays with poor reproducibility
• Puberty-related insulin resistance further complicates interpretation
• Does not add to diagnosis of comorbidities 1

Do NOT routinely screen for hypothyroidism unless there are specific clinical features (short stature with decreased growth velocity despite weight gain, which would warrant endocrinology referral) 1, 2

Additional Testing Based on Clinical Presentation

Consider these only if clinically indicated:

• AST - If ALT is elevated, to calculate AST/ALT ratio (ratio ≤1.52 suggests more advanced liver disease) 3
• Blood pressure measurement - Essential at every visit (prehypertension: >90th to <95th percentile; hypertension: ≥95th percentile) 1

Common Pitfalls

1. Ordering unnecessary tests: Research shows 29.7% of children with obesity receive potentially unnecessary thyroid or insulin tests, while only 27.3% receive recommended screening 2

2. Using HbA1c as sole diabetes screening tool: Particularly problematic in pediatrics with racial/ethnic disparities in correlation between HbA1c and ambient glucose 1

3. Testing too early: Only 10% of youth with excess weight receive glucose testing, but timing matters - wait until age 10 unless high-risk features present 4

4. Missing liver disease: NAFLD is usually asymptomatic and requires active screening with ALT 1

Summary Algorithm

For your 7-year-old with obesity:

1. Order now: Fasting lipid panel + ALT
2. Measure: Blood pressure
3. Defer: Diabetes screening until age 10 (unless high-risk features present)
4. Avoid: Insulin levels, routine thyroid testing
5. Refer to endocrinology if: Short stature with decreased growth velocity despite continued weight gain 1